196 related articles for article (PubMed ID: 11935259)
1. Postischemic hyperthermia induces Alzheimer-like pathology in the rat brain.
Sinigaglia-Coimbra R; Cavalheiro EA; Coimbra CG
Acta Neuropathol; 2002 May; 103(5):444-52. PubMed ID: 11935259
[TBL] [Abstract][Full Text] [Related]
2. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
[TBL] [Abstract][Full Text] [Related]
3. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
[TBL] [Abstract][Full Text] [Related]
4. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.
Kubo T; Nishimura S; Kumagae Y; Kaneko I
J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608
[TBL] [Abstract][Full Text] [Related]
5. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
[TBL] [Abstract][Full Text] [Related]
6. Ischemia-related changes in naive and mutant forms of ubiquitin and neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic damage.
Ahn HC; Yoo KY; Hwang IK; Cho JH; Lee CH; Choi JH; Li H; Cho BR; Kim YM; Won MH
Exp Neurol; 2009 Nov; 220(1):120-32. PubMed ID: 19666022
[TBL] [Abstract][Full Text] [Related]
7. Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.
Tan J; Town T; Crawford F; Mori T; DelleDonne A; Crescentini R; Obregon D; Flavell RA; Mullan MJ
Nat Neurosci; 2002 Dec; 5(12):1288-93. PubMed ID: 12402041
[TBL] [Abstract][Full Text] [Related]
8. Localization and cell association of C1q in Alzheimer's disease brain.
Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
10. Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu.
Inestrosa NC; Reyes AE; Chacón MA; Cerpa W; Villalón A; Montiel J; Merabachvili G; Aldunate R; Bozinovic F; Aboitiz F
Neurobiol Aging; 2005 Jul; 26(7):1023-8. PubMed ID: 15748782
[TBL] [Abstract][Full Text] [Related]
11. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain.
Kim JB; Lim CM; Yu YM; Lee JK
J Neurosci Res; 2008 Apr; 86(5):1125-31. PubMed ID: 17975839
[TBL] [Abstract][Full Text] [Related]
12. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
13. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
[TBL] [Abstract][Full Text] [Related]
14. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
16. Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier.
Kovac A; Zilkova M; Deli MA; Zilka N; Novak M
J Alzheimers Dis; 2009; 18(4):897-906. PubMed ID: 19749439
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
18. 17beta-estradiol pretreatment reduces CA1 sector cell death and the spontaneous hyperthermia that follows forebrain ischemia in the gerbil.
Plahta WC; Clark DL; Colbourne F
Neuroscience; 2004; 129(1):187-93. PubMed ID: 15489041
[TBL] [Abstract][Full Text] [Related]
19. Neuronal degeneration and glial cell-responses following trimethyltin intoxication in the rat.
Haga S; Haga C; Aizawa T; Ikeda K
Acta Neuropathol; 2002 Jun; 103(6):575-82. PubMed ID: 12012089
[TBL] [Abstract][Full Text] [Related]
20. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.
Melton LM; Keith AB; Davis S; Oakley AE; Edwardson JA; Morris CM
Glia; 2003 Oct; 44(1):1-12. PubMed ID: 12951652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
